Literature DB >> 12443686

Isulinotropic properties of Nigella sativa oil in Streptozotocin plus Nicotinamide diabetic hamster.

K M Fararh1, Y Atoji, Y Shimizu, T Takewaki.   

Abstract

The present study was designed to investigate the possible insulinotropic properties of Nigella sativa L. (N. sativa) oil in Streptozotocin plus Nicotinamide-induced diabetes mellitus in hamsters. Nicotinamide was injected intraperitoneally 15min before injection of Streptozotocin intravenously. Oral treatment with N. sativa oil began 4 weeks after induction of diabetes. Serum insulin was measured by enzymeimmunoassay. Islets insulin was stained using anti-insulin monoclonal antibody. Significant decrease in blood glucose level together with significant increase in serum insulin level were observed after treatment with N. sativa oil for 4 weeks. Big areas with positive immuno-reactivity for the presence of insulin were observed in the pancreases from N. sativa oil-treated group compared to non-treated one using immunohistochemical staining. Therefore, our data show that the hypoglycemic effect of N. sativa oil in Streptozotocin plus Nicotinamide diabetic hamsters resulted, at least partly, from a stimulatory effect on beta cell function with consequent increase in serum insulin level. These results indicate that N. sativa oil has insulinotropic properties in type 2-like model.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12443686     DOI: 10.1016/s0034-5288(02)00108-x

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  21 in total

1.  Effects of Nigella sativa and its major constituent, thymoquinone on sciatic nerves in experimental diabetic neuropathy.

Authors:  Mehmet Kanter
Journal:  Neurochem Res       Date:  2007-08-23       Impact factor: 3.996

2.  Nigella sativa and derived thymoquinone prevents hippocampal neurodegeneration after chronic toluene exposure in rats.

Authors:  Mehmet Kanter
Journal:  Neurochem Res       Date:  2007-10-11       Impact factor: 3.996

3.  Protective effects of Nigella sativa on the neuronal injury in frontal cortex and brain stem after chronic toluene exposure.

Authors:  Mehmet Kanter
Journal:  Neurochem Res       Date:  2008-04-22       Impact factor: 3.996

Review 4.  An overview on antidiabetic medicinal plants having insulin mimetic property.

Authors:  D K Patel; S K Prasad; R Kumar; S Hemalatha
Journal:  Asian Pac J Trop Biomed       Date:  2012-04

5.  Protective effects of the volatile oil of Nigella sativa seeds on beta-cell damage in streptozotocin-induced diabetic rats: a light and electron microscopic study.

Authors:  Mehmet Kanter; Meryem Akpolat; Cevat Aktas
Journal:  J Mol Histol       Date:  2010-01-05       Impact factor: 2.611

6.  PROTECTIVE EFFECT OF NIGELLA SATIVA OIL ON MYOCARDIUM IN STREPTOZOTOCIN-INDUCED DIABETIC RATS.

Authors:  E Altun; E Avci; T Yildirim; S Yildirim
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Jul-Sep       Impact factor: 0.877

7.  Thymoquinone Preserves Pancreatic Islets Structure Through Upregulation of Pancreatic β-Catenin in Hypothyroid Rats.

Authors:  Khadija Faddladdeen; Soad Shaker Ali; Safia Bahshwan; Nasra Ayuob
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-29       Impact factor: 3.168

8.  Development of a type II diabetic mellitus animal model using Micropig®.

Authors:  Myeong-Seop Lee; Ki-Duk Song; Hee-Jun Yang; Chester D Solis; Soo-Hyeon Kim; Woon-Kyu Lee
Journal:  Lab Anim Res       Date:  2012-09-26

9.  Chronic administration of a combination of six herbs inhibits the progression of hyperglycemia and decreases serum lipids and aspartate amino transferase activity in diabetic rats.

Authors:  Reza Shafiee-Nick; Ahmad Ghorbani; Farzaneh Vafaee Bagheri; Hassan Rakhshandeh
Journal:  Adv Pharmacol Sci       Date:  2012-12-09

10.  In Vitro Evaluations of Cytotoxicity of Eight Antidiabetic Medicinal Plants and Their Effect on GLUT4 Translocation.

Authors:  Sleman Kadan; Bashar Saad; Yoel Sasson; Hilal Zaid
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-28       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.